Top Markets
Coin of the day
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc.

GTTX
Kedudukan dalam Saham #34710
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in... GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
Harga Saham
$0.10409799
Disegerakkan terakhir: 2025-02-03
Modal Pasaran
$5.07M
Perubahan (1 hari)
16.43%
Perubahan (1 tahun)
0.00%
Negara
CA
Perdagangan GeneTether Therapeutics Inc. (GTTX)

Kategori

Harga GTTX dengan permodalan pasaran b
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.
GTTX
$0.10409799
Modal pasaran bagi GeneTether Therapeutics Inc.(GTTX)
Modal Pasaran: $5.07M
Sehingga August 2026, GeneTether Therapeutics Inc. mempunyai modal pasaran sebanyak $5.07M. Ini menjadikan GeneTether Therapeutics Inc. syarikat ke-34710th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran GeneTether Therapeutics Inc. dari 2022 hingga 2026
GTTX berbanding dengan 5 teratas yang paling popular stocks
Harga GTTX Aset B Pasaran B Hasilnya
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.
$112,005 $5.07M
$5.452T +107,595,682.79%
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.
$92,244.52 $5.07M
$4.490T +88,613,061.30%
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.
$85,513.92 $5.07M
$4.162T +82,147,425.10%
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.
$75,528.04 $5.07M
$3.676T +72,554,657.73%
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.
$58,203.00 $5.07M
$2.833T +55,911,645.09%